APP déposés

Liste des Appels à projets déposés au titre du programme PIRAMID

  • ANR Call
    Project title: "Protein-protein interaction between Hsp90 and its co-chaperone Sba1 as a new target for antifungal drugs".
    Coordinator: Patrice Le Pape (IICiMed: Cibles et Médicaments des Infections et du Cancer). Non retenu.

 

  • INCa Project
    Project title: "Protein protein Interactions involved in breast cancer".
    Coordinators laboratories: CEISAM (Adèle Laurent, ModES Team: Modelization and Spectroscopy) and UFIP (Stéphane Téletchéa, Protein Design In Silico Team). Retenu.

 

  • Interdisciplinary Call 2016
    Project title: "Development of new inhibitors of the homologue combinaison : new approaches against chemioresistance".
    Coordinators laboratories: CEISAM (Monique Mathé-Allainmat and Jacques Lebreton - Symbiose Team: Multi-step synthesis and Bioscience) and UFIP (Fabrice Fleury, Mechanism and regulation of DNA repair Team). 1ère phase : retenu et 2ème phase : non retenu.
  • ANR CallPRC AAPG ANR 2017
    Project title: "Targeting IL‐15 to Antagonize its action through the Gamma chain Receptor in inflammation".
    Project acronym: ISAnGaR
    Coordinator: Erwan Mortier (CRCINA - Immunobiology of Human αβ and γδ T cells and Immunotherapeutic Applications Team) / CEISAM (ModES: Modelization and Spectroscopy and SYMBIOSE: Multi-step synthesis and Bioscience, Teams). 1ère phase : retenu.

 

  • ANR Call: PRC AAPG ANR 2017
    Project title: "A new strategy to fight asthma, Rac inhibition".
    Project acronym: STAIR
    Coordinator: Vincent Sauzeau (Institut du thorax - Vascular Risks Team) / CEISAM (ModES and SYMBIOSE Teams). 1ère phase : non retenu.

 

  • PHC Tournesol DoIFad :
    Project title: "Methodologicals development on protein-protein interactions".
    Coordinator: Adèle Laurent (CEISAM - ModES Team). Non retenu.
  • ANR Call
    Project title: "Hsp90/Sba1: a new protein-protein interaction target for antifungal drug discovery".
    Project acronym : PPI2CAN
    Coordinator:  Patrice Le Pape (IICiMed) /CEISAM (ModES Team: Modelization and Spectroscopy). Non retenu.

 

  • ANR CallPRC AAPG ANR 2017
    Project title: "Targeting IL‐15 to Antagonize its action through the Gamma chain Receptor in inflammation".
    Project acronym: ISAnGaR
    Coordinator: Erwan Mortier (CRCINA - Immunobiology of Human αβ and γδ T cells and Immunotherapeutic Applications Team) / CEISAM (ModES and SYMBIOSE: Multi-step synthesis and Bioscience, Teams). 2ème phase : non retenu.

 

  • AAP FRM : Programme "Chimie pour la Médecine 2018"
    Titre du projet : "Inhibiteurs de la protéine de réparation de l’ADN par recombinaison homologue, Rad51 : nouvelle voie contre la radio- et chimiorésistance".
    Coordinateurs : Fabrice Fleury (UFIP - équipe Mécanisme et régulation de la Réparation de l'ADN) et Monique Mathé-Allainmat (CEISAM -  équipe SYMBIOSE). Non retenu.

 

  •  NExT (Nantes Excellence Trajectory) Initiative Nantes University Call: "2017 Interdisciplinary Internal Research Projects"
    Project title: "Targeting Rho protein/Rho exchange factor interaction to disrupt Rho protein signaling".
    Project acronym: TROPIC
    Coordinator : Gervaise Loirand (Institut du thorax - Signaling and Vascular and Pulmonary Physiopathology Team) / CEISAM (SYMBIOSE Team) and UFIP (Protein Design In Silico Team). 1ère phase : retenu
  • NExT (Nantes Excellence Trajectory) Initiative Nantes University Call: "2017 Interdisciplinary Internal Research Projects"
    Project title: "Targeting Rho protein/Rho exchange factor interaction to disrupt Rho protein signaling".
    Project acronym: TROPIC
    Coordinator : Gervaise Loirand (Institut du thorax - Signaling and Vascular and Pulmonary Physiopathology Team) / CEISAM (SYMBIOSE: Multi-step synthesis and Bioscience, Team) and UFIP (Protein Design In Silico Team). 2ème phase : retenu.

 

  • AAP Ligue contre le cancer
    Titre du projet :
    Exploration du Trafic IntraCellulaire CytoKINique en condition physiologique et pathoplogique
    Acronyme :
    TRAICKIN
    Coordinateur : Erwan Mortier (CRCINA - équipe Biologie de l'interleukine-15 et Applications Thérapeutiques) / CEISAM (équipe SYMBIOSE : SYnthèse Multiétapes et BIOSciencE). Retenu